Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Volin

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Bone Marrow Transplantation|February 8, 2005
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplantsG Gahrton, S Iacobelli, J Apperley, et al.
Bone Marrow Transplantation|February 21, 2007
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myelomaM Schmidt-Hieber, I W Blau, R Trenschel, et al.
Bone Marrow Transplantation|April 21, 2001
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)B Björkstrand, H Svensson, H Goldschmidt, et al.
Blood|December 15, 1996
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow TransplantationB B Björkstrand, P Ljungman, H Svensson, et al.
Bone Marrow Transplantation|November 27, 2012
Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantationG W Basak, L C de Wreede, A van Biezen, et al.
Bone Marrow Transplantation|April 26, 2016
Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working PartyC Koenecke, D Heim, A van Biezen, et al.
Bone Marrow Transplantation|December 14, 2011
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioningJ Casper, J Holowiecki, R Trenschel, et al.
Bone Marrow Transplantation|November 8, 2016
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Bone Marrow Transplantation|January 24, 2017
Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow TransplantationJ Schetelig, L C de Wreede, M van Gelder, et al.
Bone Marrow Transplantation|July 6, 2017
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Bone Marrow Transplantation|February 8, 2005
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplantsG Gahrton, S Iacobelli, J Apperley, et al.
Bone Marrow Transplantation|February 21, 2007
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myelomaM Schmidt-Hieber, I W Blau, R Trenschel, et al.
Bone Marrow Transplantation|April 21, 2001
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)B Björkstrand, H Svensson, H Goldschmidt, et al.
Blood|December 15, 1996
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow TransplantationB B Björkstrand, P Ljungman, H Svensson, et al.
Bone Marrow Transplantation|November 27, 2012
Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantationG W Basak, L C de Wreede, A van Biezen, et al.
Bone Marrow Transplantation|April 26, 2016
Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working PartyC Koenecke, D Heim, A van Biezen, et al.
Bone Marrow Transplantation|December 14, 2011
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioningJ Casper, J Holowiecki, R Trenschel, et al.
Bone Marrow Transplantation|November 8, 2016
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Bone Marrow Transplantation|January 24, 2017
Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow TransplantationJ Schetelig, L C de Wreede, M van Gelder, et al.
Bone Marrow Transplantation|July 6, 2017
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Pageof 14